GRI Bio Corporation - GRI Net Assets per Single Share

Public company logo of gribio.com (GRI)

Exclusive patents in iNKT regulation and lobbyist support create a powerful defensive moat for GRI Bio, Inc. (GRI). Supply chain reliability is ensured by express delivery of biomaterials with thermal control. The trend in book value per share clearly demonstrates capitalization, where 4.70 determines the current status of the parameter. Growth prospects depend on the completion of clinical phases, while R&D risks are already priced in.

Accounting Value of a Share: GRI Bio Inc (GRI) for 02/21/2024 - 10/27/2026

gribio.com - analytical breakdowns and key metrics (GRI)

- price and consensus price forecast:
Stock Price GRI Bio Corp|GRI - Analyst Median Target
- market capitalization data:
Market Value GRI Bio, Inc.|GRI - Full Business Value
- book capitalization data:
Book Value per Share GRI Bio|GRI - Accounting Value of Company|Market Capitalization to Book Value Ratio gribio.com|GRI - Company Total Assets
- debt and liquidity data:
Debt to Equity GRI Bio, Inc.|GRI - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity GRI Bio|GRI - Company Total Debt|Debts to Book Capitalization GRI Bio, Inc.
Analysis of all company metrics:GRI Bio Corp (GRI)
Signature product of GRI Bio

By holding patents and controlling the outsourcing of biosubstances, GRI Bio, Inc. (GRI) is accumulating valuable intangible assets that directly impact its capitalization. This indicator reflects the residual value of net assets per share after deducting all liabilities, allowing investors to assess the business's intrinsic value through GURU.Markets tools. By analyzing the book value per share, an investor can determine the extent of the premium paid relative to the company's actual assets.

Competitor analysis

Book Value per Share ARGX (Argenx)|BNTX: Net Assets per Share|Net Assets per Single Share Abivax Corp (ABVX)|admabiologics.com (ADMA) - Share Book Value|PTGX - Book Value per Share|Accounting Value of a Share Immunovant Inc|Book Value per Share KNSA|Book Value per Share GRFS (Grifols Biemat)|Net Assets per Single Share Adaptive Biotechnologies|celldex.com - Accounting Value of a Share|AUPH: Net Assets per Single Share|BCRX - Accounting Value per Share|VERA: Book Value per Share|Book Value per Share Dianthus Corp|PHVS - Accounting Value per Share|Accounting Value of a Share AbCellera Corp|TRML (Tourmaline Bio) - Book Value per Share|Net Assets per Share PGEN (Precigen Inc)|Pharming - Net Assets per Single Share|Nektar Corp - Accounting Value per Share|UPB: Net Assets per Single Share|zenasbio.com (ZBIO) - Accounting Value per Share|IMNM: Accounting Value per Share|GOSS (Gossamer Bio Inc) - Book Value per Share|Net Assets per Single Share KalVista Pharmaceuticals Inc (KALV)|Equity per Share Septerna Pharma|Pieris Pharmaceuticals - Book Value per Share|Net Asset Value per Share savarapharma.com (SVRA)|RIGL (Rigel Pharmaceuticals, Inc.) - Book Value per Share|AnaptysBio Inc - Book Value of One Share|Net Assets per Single Share Astria Pharma (ATXS)|ENGN - Accounting Value of a Share|RAPT Therapeutics, Inc. - Book Value per Share|Net Assets per Share Aerovate Therapeutics|ACRS - Accounting Value per Share|Accounting Value of a Share Kyverna Therapeutics Inc.|Book Value per Share Tiziana Life Sciences PLC (TLSA)|Net Assets per Single Share Cabaletta Bio Inc (CABA)|Book Value per Share VTYX|theratech.com - Net Assets per Share|AVTX (Avalo Therapeutics) - Net Assets per Single Share|Eledon Pharmaceuticals Inc. (ELDN) - Net Asset Value per Share|Accounting Value per Share Agenus Inc AGEN|Climb Bio, Inc (CLYM) - Accounting Value of a Share|ZURA: Book Value per Share|Net Assets per Share ATYR|Net Assets per Single Share Adagene ADAG|Equity per Share ikenaoncology.com (IMA)|Shattuck Labs - Book Value per Share|EQ - Accounting Value per Share|Accounting Value per Share CNTB (Connect Pharma)|IMUX - Net Assets per Share|Book Value per Share ATRA (atarabio.com)|IFRX (InflaRx) - Book Value of One Share|XFOR - Net Assets per Single Share|Accounting Value of a Share Adicet|CELU (Celularity Inc.) - Book Value per Share|Net Assets per Share INMB (inmunebio.com)|Barinthus Biotherapeutics plc (BRNS) - Net Assets per Single Share|Share Book Value Kezar Life Sciences Inc. KZR|Book Value per Share SAB Biotherapeutics, Inc (SABS)|AKTX - Accounting Value of a Share|ENLV: Book Value per Share|QTTB (Q32 Bio) - Book Value per Share|GOVX - Net Assets per Single Share|Accounting Value of a Share EDSA|Net Assets per Single Share IBIO (iBio Corp)|Accounting Value per Share carismatx.com (CARM)|Book Value per Share XTLB (XTL Biopharmaceuticals)|BOLT - Book Value per Share|Accounting Value per Share HCW Biologics Inc (HCWB)|APVO - Accounting Value of a Share|AIM ImmunoTech - Book Value per Share|ADTX (Aditxt, Inc.) - Net Assets per Share|Net Assets per Single Share XRTX|Accounting Value per Share HIND|Net Assets per Single Share REVB (Revelation Biosciences, Inc.)|Accounting Value per Share Indaptus Therapeutics Inc INDP|Accounting Value per Share SCNI (Scinai)|CalciMedica Inc - Book Value per Share|Affimed Therapeutics (AFMD) - Net Assets per Single Share|ALLK - Equity per Share|Book Value per Share HOOK|IGM Biosciences (IGMS) - Net Asset Value per Share|iTeos - Book Value per Share|Book Value of One Share OCEA|TC Biopharm (TCBP) - Net Assets per Single Share|Accounting Value of a Share thirdharmonicbio.com (THRD)